Skip Navigation


Radiation Protection Dosimetry Advance Access originally published online on December 9, 2008
Radiation Protection Dosimetry 2008 132(2):273-274; doi:10.1093/rpd/ncn282
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
132/2/273    most recent
ncn282v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Portier, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Portier, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press 2008. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Discussion and summary

Christopher Portier*

National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA

* Corresponding author: portier@niehs.nih.gov

The first 10% of the full text of this article appears below.

The presentations at this workshop demonstrate that, while there have been tremendous strides in the ability to cure childhood leukaemias, the understanding of the genetic and environmental causes of this class of diseases is limited. The epidemiological and the molecular evidence all suggest that childhood leukaemia derives from a multistage process where the initial event starting the process is either inherited or the result of a DNA damaging event during gestation(1). From that initial event, the progression to disease has to occur fairly rapidly because the peak incidence occurs very early in life at around 1–3 y of age depending upon the type of leukaemia(2,3). At later ages, the incidence drops off quite dramatically with a >90% smaller incidence beyond age 15.

As discussed at the workshop and in the . . . [Full Text of this Article]


   FUNDING
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?